Research Diagnosis Related Groups (DRG) level SNF discharge quality outcomes for Hillcrest Hospital South located at 8801 S 101St East Ave, Tulsa, OK, 74133 & includes data from NPIs 1750661534
Dexur analyzed Q4 2018 (October to December 2018) Medicare claims data to benchmark skilled nursing facilities (SNF) discharges rates for Hillcrest Hospital South compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Oklahoma Total Hospitalizations (Oct 2018 to Dec 2018) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 808 | 756 | ||||||||||
| Surgical | 177 | 170 | ||||||||||
| Non Surgical | 631 | 586 | ||||||||||
| Cardiovascular | 236 | 224 | ||||||||||
| General Medicine | 124 | 113 | ||||||||||
| Pulmonology | 91 | 88 | ||||||||||
| Gastroenterology & Endocrinology | 87 | 78 | ||||||||||
| Orthopedics | 71 | 70 | ||||||||||
| Urology | 68 | 64 | ||||||||||
| Neurology | 41 | 36 | ||||||||||
| General Surgery | 39 | 35 | ||||||||||
| Oncology & Hematology | 18 | 16 | ||||||||||
| Spine | 14 | 14 |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Oklahoma Total Hospitalizations (Oct 2018 to Dec 2018) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acute Myocardial Infarction | ||||||||||||
| DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 281: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Heart Failure And Shock | ||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
| DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 310: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Chest Pain | ||||||||||||
| DRG 313: CHEST PAIN | ||||||||||||
| Percutaneous Cardiovascular Procedures With Coronary Artery/Stent |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Oklahoma Total Hospitalizations (Oct 2018 to Dec 2018) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
| DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cellulitis |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Oklahoma Total Hospitalizations (Oct 2018 to Dec 2018) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chronic Obstructive Pulmonary Disease | ||||||||||||
| DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Simple Pneumonia And Pleurisy | ||||||||||||
| DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Oklahoma Total Hospitalizations (Oct 2018 to Dec 2018) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Diabetes | ||||||||||||
| G.I.Hemorrhage | ||||||||||||
| G.I. Obstruction |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Oklahoma Total Hospitalizations (Oct 2018 to Dec 2018) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Oklahoma Total Hospitalizations (Oct 2018 to Dec 2018) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Renal Failure | ||||||||||||
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Kidney And Urinary Tract Infections | ||||||||||||
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Oklahoma Total Hospitalizations (Oct 2018 to Dec 2018) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracranial Hemorrhage Or Cerebral Infarction |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Oklahoma Total Hospitalizations (Oct 2018 to Dec 2018) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Infections And Parasitic Diseases With O.R. Procedure |